Immunology

Closer to the source of the itch

Psoriasis is an inflammatory skin condition that affects some 125 million people worldwide. It is characterized by itchy, scaly skin plaques. The exact cause of psoriasis is unclear. But mounting evidence implicates the immune ...

Arthritis & Rheumatism

Immunotherapy reduces cardiovascular risk in rheumatoid arthritis

Immunotherapy reduces cardiovascular risk in patients with rheumatoid arthritis, according to research presented today at Frontiers in CardioVascular Biology (FCVB) 2016 by Professor Aida Babaeva, head of the Department of ...

Arthritis & Rheumatism

Rheumatism drug also effective at half dose

The treatment of moderately active rheumatoid arthritis with the tumour necrosis factor inhibitor Etanercept achieves excellent success in more than 80 per cent of patients. With this method, the success can be maintained ...

Arthritis & Rheumatism

Smoking impairs treatment response in inflammatory back arthritis

Smoking impairs the response to biological drugs used to treat inflammatory arthritis affecting the lower back, known as axial spondyloarthritis, or AxSpA, for short, reveals research published online in the Annals of the ...

page 1 from 2